Archive for the ‘Activism’ Category

FREE LDN Talk in Madison – April 25

iu-8

LDN Talk in Madison, Wisconsin

When:  April 25th, 6:30-8:00pm

Where: Door Creek Church, 6602 Dominion Drive, Madison, Wisconsin 

Who: Linda Elsegood, David Yeazel, Medical Professionals and Patients

Cost:  FREE

Register:  email  

For more on LDN:  https://madisonarealymesupportgroup.com/2016/12/18/ldn/

https://madisonarealymesupportgroup.com/2018/10/30/ldn-an-overview-of-clinical-applications/

https://madisonarealymesupportgroup.com/2017/06/12/ldn-reduced-pro-inflammatory-cytokines-in-fm-after-eight-weeks/

https://madisonarealymesupportgroup.com/2018/05/18/bullseye-low-dose-naltrexone-lyme-disease-documentary/

https://madisonarealymesupportgroup.com/2018/07/16/low-dose-naltrexone-for-lyme-living-with-lyme-podcast/

https://madisonarealymesupportgroup.com/2019/03/19/sjogrens-syndrome-clinical-benefits-of-low-dose-naltrexone-therapy/

https://madisonarealymesupportgroup.com/2019/01/16/ldn-cbd/

What is LDN, How LDN Works, Conditions LDN can Treat and Formulations of LDN: https://lnkd.in/gTCgvgC

Information Packs: https://lnkd.in/gFkN2_e

LDN Clinical Trial and Studies – can be sorted by conditions: https://lnkd.in/gjYffHy

Testimonials from Users and Medical Professionals – can be sorted by conditions: https://lnkd.in/gNSiiiC

Free Conference Presentations – 2013, 2014, and 2016: https://lnkd.in/geHGKVc

Much more is on the website: https://lnkd.in/gWfhg4H

Antibiotics & Lyme: Everything You Need to Know

https://www.bca-clinic.de/en/antibiotics-and-lyme-disease-everything-you-need-to-know/

Antibiotics And Lyme Disease: Everything You Need To Know

 

Antibiotics are often the default treatment path for many doctors when it comes to Lyme disease. However, they are not always effective. Lyme disease is a complicated disorder that we don’t yet fully understand. Yes, antibiotics work to a certain degree, but in some cases they don’t fully eradicate the disease, leading to years of debilitating symptoms for patients. So when are antibiotics effective, which types are effective, and in cases where they fail to get rid of the Lyme bacteria, what happens? These aren’t easy questions to answer, as much Lyme disease knowledge is still murky at best. However, it’s important to try to understand exactly how antibiotics and Lyme disease work in tandem.

Firstly, let’s look at when they are effective. Lyme disease can be broadly split into two stages: acute and chronic. Acute Lyme lasts for a few weeks, and is easily identifiable by the presence of a bullseye rash. This distinctive Lyme symptom is present in the majority of cases in the initial stages of the disease, and is one of the best indicators available to doctors and patients alike. If the condition is presented to a medical professional in the acute stages, Lyme disease can almost always be eradicated by antibiotics. Successful treatment is usually achieved by a short course of oral antibiotics, namely doxycycline or amoxicillin. However, if this acute stage of the disease is missed and it progresses to the chronic stage, antibiotics alone will not be enough to fight off the disorder.

Many doctors prescribe antibiotics for patients who have a diagnosis of Lyme disease.

Chronic Lyme disease is a much more diverse and complicated condition than acute Lyme. This is because inflammation also plays a significant role in the symptoms. Many doctors follow the traditional line of thinking that Lyme, being caused by the presence of bacteria, can be treated successfully using synthetic microbes (i.e. antibiotics), like many other conditions and diseases. While this reasoning may be structurally sound, it doesn’t take into account the body’s own reaction to the bacteria, and how that can kickstart a whole set of new and debilitating symptoms. On top of that, individuals will have different reactions to the borrelia bacteria, depending on their constitution. Lyme disease is not a one-size-fits-all condition like the flu, which has very little variance in its symptoms on a person-to-person level.

The symptoms of chronic Lyme vary wildly, but usually include joint pain, muscle pain, aches, soreness and a chronic sense of fatigue. All these symptoms are a result of the immune system’s response to the bacteria. For some reason, the immune system goes into overdrive when faced with a long-term borrelia infection, resulting in severely debilitating symptoms, even when the actual presence of the bacteria may be minimal. Obviously, antibiotics administered at this point will have zero effect on inflammation symptoms, as they are the body’s own doing. Yet Lyme-illiterate doctors will often insist on antibiotics as the only treatment path for chronic Lyme disease, if they believe the diagnosis at all (chronic Lyme is still not officially recognised by the CDC).

Treating chronic Lyme requires a more nuanced touch. The medical staff at BCA-clinic in Augsburg, Germany, have been experts in Lyme disease for a long time. Their approach to treatment is designed to tackle both the inflammation and infection symptoms of the disease. The first thing to do is test the patient to see what the ratio of inflammation and infection actually is. Some people might have a lot of inflammation and only traces of a bacterial infection, while some others might have the complete opposite. Successful Lyme disease treatment constitutes knowing the difference between the two, and responding accordingly. Antibiotics are only half of the approach here, as they solely deal with infection. For the inflammatory symptoms, herbal supplements and diet adjustments are necessary.

Antibiotics can be helpful in fighting chronic Lyme, but they really only deal with the infection side of the disease, not the inflammation.

Borrelia bacteria have been proven to be surprisingly resistant to antibiotic treatment. If they are left in the system, they can adapt to survive the natural immune response, as well as tolerating various forms of common antibiotic. Borrelia exists in two separate forms: the spirochete and the ‘cell wall’ variant, sometimes known as the ‘cyst’ form. Under stress, the spirochete will adapt to the cyst form, making it much more resistant to antibiotics. It is likely that the majority of chronic Lyme sufferers have both borrelia forms present in their systems at any given time. Therefore, it is crucial to combine antibiotics in order to attack the bacteria from all angles. This requires an experienced medical professional who is well-versed in Lyme; unfortunately, many doctors are not.

It’s important to back up any heavy antibiotic use with a probiotic, in order to keep your gut healthy. Knowing how long to stay on a course of a particular antibiotic is also necessary. If you suspect you have chronic Lyme disease, getting help from an expert in the field should be paramount. The disease can affect people for many years, and is very hard to treat if you don’t know what you’re doing. While antibiotics are an important component, they are not totally reliable in every case. When it comes to chronic Lyme, they should be used as part of a broader treatment process.

_____________________

**Comment**

A few points:

  1. There is legitimate science behind antibiotics killing pathogens which is why it is a “default.”
  2. The jury’s really still out on whether or not acute cases are “cured” by short-term antibiotics. According to Microbiologist Tom Greer, treatment failures have been documented since the beginning. Who’s to say a person treated early doesn’t go on to develop arthritis or even mental illness and never connects the dots to a past Lyme/MSIDS infection? The M.D. who wrote this thinks we should be concerned:  https://madisonarealymesupportgroup.com/2017/06/10/the-coming-pandemic-of-lyme-dementia/
  3. There are various reasons why antibiotics sometimes do not work. Until this is teased out, there is a lot that remains unknown. We know the organisms are stealthy and evade treatment, and I don’t believe that’s just in the case of antibiotics. Also, there are nuances with antibiotic treatment that most doctors aren’t privy to. For more on this see:  https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/. Also, for an informative video by Dr. Burrascano, a well known and experienced Lyme literate doctor, see: https://www.ilads.org/dr-burrascano-happy-holidays/?. Drug blood levels are crucial and need to be addressed. I highlight the 40 minute video where he discusses treatment nuances here:  https://madisonarealymesupportgroup.com/2019/02/22/why-mainstream-lyme-msids-research-remains-in-the-dark-ages/.  I’ve seen a lot of patients through the years and the ones that do the poorest are those that have tried alternative things for years, unwilling to even try antibiotics, and those who have used antibiotics indiscriminately. What I mean by that is they’ve been given the CDC mono-therapy of doxycycline for long periods of time without consideration of and treatment for the various forms of Lyme or coinfections. Doxy, while a great front-line drug that works against many of the pathogens will not work against some – like Babesia for instance. Also, in my opinion, there are some doctors who have not taken a holistic approach and have neglected key aspects of treatment like detoxification and gut health. To steal a quote from Dr. Burrascano, “Now is the time for pristine health habits.” This illness will test your metal in every way, shape, and form.  Learn ALL you can to improve your immune system, but let me be clear – antibiotics DO kill things.  It’s proven. Lyme/MSIDS finds and uses your weaknesses against you. The best thing you can do is find out and address your weaknesses.
  4. If you study the Lyme organism, you realize that it is pleomorphic and certain antibiotics (doxycycline) will only address certain forms – potentially leaving other forms to emerge later. This is a real concern.  I think it folly to use the mono-therapy on anyone – acute or chronic. Researcher Eva Sapi has shown that high doses of doxy actually throws the spirochete into the non-cell wall form: https://www.dovepress.com/evaluation-of-in-vitro-antibiotic-susceptibility-of-different-morpholo-peer-reviewed-article-IDR. My main concern is the potential for this to be happening to folks treated early with only doxy.  While this author states there are only 2 forms of the bacteria, there are actually 4 and effective treatment takes this into account:
  5. Once infected, a person should be on the look-out for future symptoms and work with an experienced practitioner that understands the nature of the organisms involved.
  6. What IS murky is the Bull’s-eye rash criteria that’s been used for decades keeping thousands from a proper diagnosis. The percentage who gets it varies wildly (27-80%) clearly demonstrating the need for better markers. While those who DO have the rash HAVE Lyme disease, those who DON’T – CAN ALSO HAVE Lyme disease.  I can’t be any clearer.
  7. Some antibiotics DO address inflammation:  https://madisonarealymesupportgroup.com/2017/06/04/minocycline-for-ms-and-much-more/.  Mino was one of the most effective drugs for me as it crosses the blood/brain barrier, kills pathogens AND addresses inflammation. Another thing that really has been a game-changer for me is MSM:  https://madisonarealymesupportgroup.com/2018/03/02/dmso-msm-for-lyme-msids/. Interesting note: MSM did nothing while I was in full-fledged treatment. It was only AFTER treatment that this seemed to help. I noticed a 70% reduction in pain within a week and had nearly none in a month’s time.  Also, consider systemic enzymes for their anti-inflammatory properties:  https://madisonarealymesupportgroup.com/2016/04/22/systemic-enzymes/. Interestingly, these also only worked after treatment for me. Also consider LDN & CBD oil:  https://madisonarealymesupportgroup.com/2016/12/18/ldn/, https://madisonarealymesupportgroup.com/2019/02/10/the-endocannabinoid-system-and-the-important-role-it-plays-in-human-health/
  8. In sum, treating this complex illness will be one of the most challenging things you’ve ever done. Partner with an experienced practitioner and learn all you can. Bring ideas to the table if you feel them worth consideration. Feeling overwhelmed is part of this process but if you learn one thing every day by the end of the year, you’ve learned 365 new things!  Keep an open mind and talk to others. While what they’ve done may or may not work for you, you’ve learned something that may help someone else, and develop the attitude that you are willing to try everything and the kitchen sink if it works.
Chin up. You can do this!  

 

New Comprehensive Testing for Vector-borne Disease – Medical Diagnostic Labs

http://www.genesisbiotechgroup.com/press/VectorBornePR_Final_Branded_3.18.2019.pdf

FOR IMMEDIATE RELEASE

Medical Diagnostic Laboratories, L.L.C., Fights Tick- and Mosquito-borne Epidemic with New Comprehensive Testing for Vector-borne Disease.

Hamilton, NJ., March 18, 2019 –Medical Diagnostic Laboratories, L.L.C., (MDL), a Genesis Biotechnology Group® (GBG) company and CLIA-certified, CAP-accredited laboratory specializing in high-complexity, state-of-the-art, automated DNA-based molecular analyses, has expanded its testing to include a comprehensive program for the detection of vector-borne diseases.

Unfortunately, new tick- and mosquito-borne diseases continue to emerge, increasing in prevalence year after year. The Centers for Disease Control and Prevention (CDC) has reported that the number of disease cases from mosquitoes, ticks, and fleas has tripled from 2004 to 2016. Ticks and mosquitos that carry bacterial, parasitic, and viral pathogens continue to increase in number, species, and geographic range. Currently, tick-borne diseases are widely distributed throughout the United States, with major concentrations in the Northeast, Upper Midwest, and across the middle of the Midwest and Atlantic states.

To combat this growing medical issue, MDL has renewed their efforts to provide the most comprehensive vector-borne disease test menu. Their multi-phase implementation will offer a comprehensive platform blending direct (molecular testing) and indirect (serological) testing methods. This important information helps providers determine their patients’ exposure risk, the pathogen(s) associated with often-overlapping symptomatology, the most effective antimicrobial treatment for active infections, and appropriate prophylactic treatment for exposure. Phase Two, expected to launch in Q2 2019, will feature tick identification. MDL will also offer immune status testing using flow cytometry to evaluate CD3-/CD8-/CD57+ natural killer cells and other immune markers to help assess treatment response for acute and Post-treatment Lyme disease Syndrome patients.

Testing will detect a variety of pathogens associated with tick-borne disease including:

  • Borrelia species (US and European strains of Lyme disease and Relapsing fever)
  • Rickettsia species (Spotted Fever and Typhus Fever)
  • Ehrlichia species (Ehrlichiosis)
  • Francisella tularensis (Tularemia)
  • Babesia species (Babesiosis)
  • Powassan virus and Bourbon virus
  • Mosquito-borne viruses will include Zika virus, Chikungunya virus, Dengue virus, Japanese Encephalitis virus, and Usutu virus.

This is not the first time that MDL has been on cutting-edge of clinical diagnostic testing for vector-borne disease. In 2001 they were the first lab to identify and report, in peer-reviewed scientific journals, co-infections of Ixodes scapularis (deer tick) with Borrelia burgdorferi and Bartonella henselae. According to Dr. Eli Mordechai, Chief Executive Officer (CEO),

“Our laboratory has always poured resources into vector-borne research by developing and enhancing tests in concert with our national and international clinician clients. We’re committed to leading the way in vector-borne diagnostics and partnering with healthcare providers to offer patients the best care possible”.

About MDL

MDL is a CLIA-certified infectious disease laboratory specializing in high-complexity, state-of-the-art, automated, DNA-based molecular analyses. Using unique molecular techniques, MDL provides clinicians from many specialties valuable information to assist in the diagnosis, evaluation, and treatment of viral, fungal, and bacterial infections. MDL is a member of the Genesis Biotechnology Group located in Hamilton, New Jersey, in “Einstein’s Alley”, the research and technology corridor of New Jersey.

About GBG

GBG is a consortium of vertically-integrated corporate research entities, which facilitates the overall market implementation and delivery of biomedical science products and services related to diagnostics and drug discovery. Through the consolidation of research activities, and the collaboration of diverse groups of scientists with expertise in molecular biology, genetics, high throughput screening (HTS), pharmacology, molecular modeling, and medicinal chemistry, GBG is well-positioned to create and sustain complex research platforms in drug discovery and the design of surrogate biomarkers for chronic diseases.

To find out more, please visit www.mdlab.com.

Scott Gygax, Ph.D. sgygax@mdlab.com609.570.LYMEwww.mdlab.com

___________________

More on testing:  https://madisonarealymesupportgroup.com/2018/09/12/lyme-testing-problems-solutions/

https://madisonarealymesupportgroup.com/2018/01/16/2-tier-lyme-testing-missed-85-7-of-patients-milford-hospital/

https://madisonarealymesupportgroup.com/2018/10/12/direct-diagnostic-tests-for-lyme-the-closest-thing-to-an-apology-you-are-ever-going-to-get/

https://madisonarealymesupportgroup.com/2018/08/08/ny-grants-approval-of-igenexs-lyme-immunoblot-tests/

https://madisonarealymesupportgroup.com/2017/10/17/igenex-introduces-3-new-lyme-tests/

https://madisonarealymesupportgroup.com/2018/10/12/paving-the-way-for-better-lyme-diagnostic-tests/

https://madisonarealymesupportgroup.com/2016/12/07/igenex-presentation/

https://madisonarealymesupportgroup.com/2017/12/13/suppression-of-microscopy-for-lyme-diagnostics-professor-laane/

https://madisonarealymesupportgroup.com/2018/09/27/spirochete-culture-microscopy-videos-see-whats-inside-you/

https://madisonarealymesupportgroup.com/2018/09/29/microscopy-of-spirochaete-biofilm/

 

Association of American Physicians and Surgeons Statement on Federal Vaccine Mandates

https://aapsonline.org/measles-outbreak-and-federal-vaccine-mandates/

Statement on Federal Vaccine Mandates

Feb. 26, 2019

The Association of American Physicians and Surgeons (AAPS) strongly opposes federal interference in medical decisions, including mandated vaccines. After being fully informed of the risks and benefits of a medical procedure, patients have the right to reject or accept that procedure. The regulation of medical practice is a state function, not a federal one. Governmental preemption of patients’ or parents’ decisions about accepting drugs or other medical interventions is a serious intrusion into individual liberty, autonomy, and parental decisions about child-rearing.

A public health threat is the rationale for the policy on mandatory vaccines. But how much of a threat is required to justify forcing people to accept government-imposed risks? Regulators may intervene to protect the public against a one-in-one million risk of a threat such as cancer from an involuntary exposure to a toxin, or-one-in 100,000 risk from a voluntary (e.g. occupational) exposure. What is the risk of death, cancer, or crippling complication from a vaccine? There are no rigorous safety studies of sufficient power to rule out a much higher risk of complications, even one in 10,000, for vaccines. Such studies would require an adequate number of subjects, a long duration (years, not days), an unvaccinated control group (“placebo” must be truly inactive such as saline, not the adjuvant or everything-but-the-intended-antigen), and consideration of all adverse health events (including neurodevelopment disorders).

Vaccines are necessarily risky, as recognized by the U.S. Supreme Court and by Congress. The Vaccine Injury Compensation Program has paid some $4 billion in damages, and high hurdles must be surmounted to collect compensation. The damage may be so devastating that most people would prefer restored function to a multimillion-dollar damage award.

The smallpox vaccine is so dangerous that you can’t get it now, despite the weaponization of smallpox. Rabies vaccine is given only after a suspected exposure or to high-risk persons such as veterinarians. The whole-cell pertussis vaccine was withdrawn from the U.S. market, a decade later than from the Japanese market, because of reports of severe permanent brain damage. The acellular vaccine that replaced it is evidently safer, though somewhat less effective.

The risk: benefit ratio varies with the frequency and severity of disease, vaccine safety, and individual patient factors. These must be evaluated by patient and physician, not imposed by a government agency.

Measles is the much-publicized threat used to push for mandates, and is probably the worst threat among the vaccine-preventable illnesses because it is so highly contagious. There are occasional outbreaks, generally starting with an infected individual coming from somewhere outside the U.S. The majority, but by no means all the people who catch the measles have not been vaccinated. Almost all make a full recovery, with robust, life-long immunity. The last measles death in the U.S. occurred in 2015, according to the Centers for Disease Control and Prevention (CDC). Are potential measles complications including death in persons who cannot be vaccinated due to immune deficiency a  justification for revoking the rights of all Americans and establishing a precedent for still greater restrictions on our right to give—or withhold—consent to medical interventions? Clearly not.

Many serious complications have followed MMR vaccination, and are listed in the manufacturers’ package insert, though a causal relationship may not have been proved. According to a 2012 report by the Cochrane Collaboration, “The design and reporting of safety outcomes in MMR vaccine studies, both pre- and post-marketing, are largely inadequate” (cited by the National Vaccine Information Center).

Mandate advocates often assert a need for a 95% immunization rate to achieve herd immunity. However, Mary Holland and Chase Zachary of NYU School of Law argue, in the Oregon Law Review, that because complete herd immunity and measles eradication are unachievable, the better goal is for herd effect and disease control. The best outcome would result, they argue, from informed consent, more open communication, and market-based approaches.

Even disregarding adverse vaccine effects, the results of near-universal vaccination have not been completely positive. Measles, when it does occur, is four to five times worse than in pre-vaccination times, according to Lancet Infectious Diseases, because of the changed age distribution: more adults, whose vaccine-based immunity waned, and more infants, who no longer receive passive immunity from their naturally immune mother to protect them during their most vulnerable period.

Measles is a vexing problem, and more complete, forced vaccination will likely not solve it. Better public health measures—earlier detection, contact tracing, and isolation; a more effective, safer vaccine; or an effective treatment are all needed. Meanwhile, those who choose not to vaccinate now might do so in an outbreak, or they can be isolated. Immunosuppressed patients might choose isolation in any event because vaccinated people can also possibly transmit measles even if not sick themselves.

Issues that Congress must consider:
  • Manufacturers are virtually immune from product liability, so the incentive to develop safer products is much diminished. Manufacturers may even refuse to make available a product believed to be safer, such as monovalent measles vaccine in preference to MMR (measles-mumps-rubella). Consumer refusal is the only incentive to do better.
  • There are enormous conflicts of interest involving lucrative relationships with vaccine purveyors.
  • Research into possible vaccine adverse effects is being quashed, as is dissent by professionals.
  • There are many theoretical mechanisms for adverse effects from vaccines, especially in children with developing brains and immune systems. Note the devastating effects of Zika or rubella virus on developing humans, even though adults may have mild or asymptomatic infections. Many vaccines contain live viruses intended to cause a mild infection. Children’s brains are developing rapidly—any interference with the complex developmental symphony could be ruinous.
  • Vaccines are neither 100% safe nor 100% effective. Nor are they the only available means to control the spread of disease.

AAPS believes that liberty rights are unalienable. Patients and parents have the right to refuse vaccination, although potentially contagious persons can be restricted in their movements (e.g. as with Ebola), as needed to protect others against a clear and present danger. Unvaccinated persons with no exposure to a disease and no evidence of a disease are not a clear or present danger.

AAPS represents thousands of physicians in all specialties nationwide. It was founded in 1943 to protect private medicine and the patient-physician relationship.

Respectfully yours,

Jane M. Orient, M.D., Executive Director
Association of American Physicians and Surgeons

AutismOne 2019 Chicago Conference in May – Dr. Brown Speaking

conf-2019

Register here:  https://autismone.ticketspice.com/autism-one-2019-conference

The most rewarding educational and networking experience you can have at any autism conference!  An exceptional value as you gather new hope, answers, help, and direction.

New to the autism diagnosis? Come hear the “Newly Diagnosed” track just for you!
Yearning to learn more? Hear the “Biomedical Research and Treatments” track!

This conference will help you answer and understand important concepts:

  • Recovery from autism is possible and children get better!
  • There are medical comorbidities of autism that, when treated, allow the child to enjoy improved learning and behavior.

On the autism journey a little while? Come hear the latest research and healing information!
Medical professional? Hear renowned researchers present the latest cutting-edge autism research.

Conference track highlights include:
  • Membrane Medicine track
  • PANDAS/PANS track (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome)
  • 4th Annual International HPV Vaccine Education Symposium
  • Focus for Health Advocacy Training track
  • Chiropractic Pediatric Continuing Education Credit Program with Emphasis on Autism
  • Endocannabinoid Medicine track
  • ADHD (attention-deficit/hyperactivity disorder) track
  • Culinary Day: Culinary Day on a Budget
  • And a special surprise panel that illuminates the bigger picture that affects your family’s world

The AutismOne 2019 Conference will be held May 22-26, 2019, at the Loews Chicago O’Hare Hotel in Rosemont, IL.

“AutismOne always has the cutting-edge information years ahead of any other autism conference. You hear it first at AutismOne.” ~Janet Cakir, PhD

CONFERENCE SCHEDULE-AT-A-GLANCE

WEDNESDAY, MAY 22, LECTURES:
1:30PM-6:00PM

THURSDAY, MAY 23, LECTURES, MOVIES, PANELS:
8:30AM-10:15PM

FRIDAY, MAY 24, LECTURES AND PANELS:
8:30AM-5:45PM

SATURDAY, MAY 25, LECTURES AND PANELS:
8:30AM-7:00PM

SUNDAY, MAY 26, LECTURES:
8:45AM-1:30PM

See list of speakers:  https://autismoneconference.com/conference_speakers.html  Erica Linn, MSN & Dr. Greg Brown MD from Serenity Health in Wisconsin will be speakers at the conference.  Dr. Brown treats children and adults with Lyme/MSIDS as well as PANS/PANDAS.  He’s stated that up to 80% of his autistic and PANS/PANDAS patients are infected with Lyme/MSIDS.

For more on that connection:  https://madisonarealymesupportgroup.com/2017/10/01/panspandas-steroids-autoimmune-disease-lymemsids-the-need-for-medical-collaboration/

https://madisonarealymesupportgroup.com/2017/10/08/misdiagnosed-how-children-with-treatable-medical-issues-are-mistakenly-labeled-as-mentally-ill/

https://madisonarealymesupportgroup.com/2017/06/30/child-with-lymemsidspans-told-by-doctors-she-made-it-all-up/

https://madisonarealymesupportgroup.com/2017/10/09/today-is-panspandas-awareness-day/  Trifiletti officially diagnosed Carson with PANS, not PANDAS, due to the active co-infections found in his blood work: mycoplasma, the bacteria that causes pneumonia; coxsackie — the virus causing Hand, Foot and Mouth disease; streptococcus, the bacteria causing strep throat; bartonella and babesia — a bacteria and parasite related to Lyme disease; and yeast, Melissa Spears said.

Instead of attacking these infections, Carson’s antibodies were instead going after his brain.

https://madisonarealymesupportgroup.com/2018/03/14/dr-frid-children-lyme/